The four types of lupus are systemic lupus erythematosus (SLE), cutaneous lupus, drug-induced lupus, and neonatal lupus. Each affects the body differently, ranges in severity, and has distinct triggers. SLE is by far the most common and the one most people mean when they say “lupus,” but understanding all four helps clarify a diagnosis or make sense of what a loved one is experiencing.
Systemic Lupus Erythematosus (SLE)
SLE is the most widespread form, affecting an estimated 204,000 people in the United States alone. About 184,000 of those are women, making the condition roughly nine times more common in females than males. When doctors, news stories, or friends mention “lupus” without specifying a type, they’re almost always talking about SLE.
What makes SLE “systemic” is that it doesn’t stay in one place. The immune system, which normally fights infections, turns against the body’s own tissues and can damage the joints, skin, kidneys, blood cells, brain, heart, and lungs. The most common symptoms include persistent fatigue, fever, joint pain and swelling, and a butterfly-shaped rash across the cheeks and nose. Some people also experience fingers and toes that turn white or blue in the cold, shortness of breath, chest pain, and problems with memory or concentration.
Kidney involvement is one of the most serious complications. In a large Hong Kong study tracking patients over 20 years, roughly 56 percent of people with SLE developed kidney inflammation (lupus nephritis). That’s a strikingly high number, and kidney failure remains one of the leading causes of death among people with lupus. This is why routine blood and urine tests to monitor kidney function are a standard part of living with SLE.
Diagnosis typically starts with a blood test for antinuclear antibodies (ANA), which comes back positive in about 95 percent of SLE patients. A positive ANA alone doesn’t confirm lupus, though, since a small percentage of healthy people test positive too. More specific antibody tests help narrow it down, with certain markers found in 60 to 82 percent of confirmed SLE cases but rarely in other conditions.
Cutaneous Lupus
Cutaneous lupus is limited to the skin. It comes in three subtypes: acute, subacute, and chronic (also called discoid lupus). Each produces distinct rashes, and a skin biopsy is sometimes needed to tell them apart.
Acute cutaneous lupus is the subtype behind the classic butterfly rash that appears across the nose and cheeks. It often occurs alongside SLE and tends to flare with sun exposure. Subacute cutaneous lupus produces ring-shaped or scaly patches, usually on sun-exposed areas of the chest, back, and arms. It’s strongly linked to specific antibodies and can be triggered by certain medications.
Chronic cutaneous lupus, or discoid lupus, is the most common skin-only form. It causes thick, scaly patches that typically appear on the face, neck, and scalp. Over time, these patches expand outward, then heal inward, leaving discolored skin and sunken scars. On the scalp, discoid lupus can destroy hair follicles and cause permanent hair loss. It’s more common in smokers and in Black Americans.
One important thing to know: cutaneous lupus can progress to systemic lupus. A U.S. population-based study found that about 12 percent of people with cutaneous lupus eventually developed SLE, with an average time to progression of eight years. The risk continued climbing over time, reaching roughly 23 percent at 25 years. This doesn’t mean progression is inevitable, but it’s the reason doctors monitor cutaneous lupus patients for signs of internal organ involvement.
Drug-Induced Lupus
Drug-induced lupus looks a lot like SLE, with joint pain and inflammation around the lungs, but it has one critical difference: it’s caused by specific prescription medications and usually goes away once the drug is stopped. Symptoms typically clear within weeks of discontinuation.
The medications most commonly linked to drug-induced lupus include hydralazine (a blood pressure drug), procainamide (used for irregular heart rhythms), isoniazid (a tuberculosis treatment), minocycline (an acne antibiotic), and anti-TNF drugs used for rheumatoid arthritis and related conditions. More recently, cases have been reported with certain immunotherapy drugs and even some common acid-reflux medications.
Drug-induced lupus doesn’t typically cause the severe kidney or brain problems seen in SLE, which is one way doctors distinguish between the two. If you’ve been on a medication for months or years and develop joint pain, fatigue, or chest discomfort, it’s worth mentioning the possibility to your doctor. The connection isn’t always obvious, since drug-induced lupus can develop after years of taking a medication without issues.
Neonatal Lupus
Neonatal lupus is rare and affects newborns. It isn’t caused by the baby’s own immune system. Instead, it happens when certain antibodies from the mother cross the placenta during pregnancy and affect the baby’s developing body. The specific antibodies responsible are anti-SSA (also called anti-Ro) and anti-SSB (also called anti-La). A mother can carry these antibodies without having lupus herself, though many do have lupus or another autoimmune condition.
The most visible symptom is a skin rash present at birth or appearing within the first few months. It looks like roundish rings with a reddish border and clear skin in the center. This rash is temporary and harmless, typically fading on its own. Some babies also develop low blood cell counts or elevated liver enzymes, which usually resolve without lasting problems.
The most serious complication is a condition called congenital heart block, where the mother’s antibodies damage the electrical system in the baby’s heart. This disrupts the signals that coordinate heartbeats, making it harder for the heart to pump blood effectively. Congenital heart block is permanent and sometimes requires a pacemaker later in life. Because of this risk, pregnant women known to carry these antibodies are monitored closely with fetal heart monitoring starting in the second trimester.
How the Four Types Overlap and Differ
The four types of lupus share an underlying theme: the immune system is either attacking the body’s own tissues or, in the case of neonatal lupus, a mother’s immune proteins are affecting her baby. But the scope of damage, the triggers, and the outlook vary enormously.
- SLE is chronic, affects multiple organs, and requires long-term management.
- Cutaneous lupus stays in the skin for most people, though it carries a meaningful risk of progressing to SLE over time.
- Drug-induced lupus is reversible once the triggering medication is stopped.
- Neonatal lupus is temporary in most cases, with the notable exception of heart block.
Because symptoms overlap significantly, especially between SLE and drug-induced lupus, diagnosis often involves a combination of blood tests, symptom history, and a careful review of any medications you’re taking. The ANA test is the standard starting point, but more targeted antibody tests are needed to pin down the specific type and guide treatment.